Goldman Sachs’s Endologix Inc ELGX Stock Holding History

Goldman Sachs’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-60	Closed	-$3K	–	7007
2017 Q2	$3K	Buy	+60	New	+$3.53K	﹤0.01%	6722

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Goldman Sachs's ELGX Position: Q3 2019 in Review

Goldman Sachs sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 76,798 shares — an estimated $556K sold.

Goldman Sachs first reported a position in ELGX in Q2 2013 and held it in 25 quarters. The position peaked at $63.4M in Q1 2015. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

Goldman Sachs reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
Goldman Sachs sold 76,798 Endologix Inc shares in Q3 2019, an estimated $556K.
Goldman Sachs first reported a position in Endologix Inc in Q2 2013 and held it in 25 quarters.
Goldman Sachs's Endologix Inc position peaked at $63.4M in Q1 2015.
63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.